A Trademark

Trademark Overview

On Tuesday, October 26, 2021, a trademark application was filed for A with the United States Patent and Trademark Office. The USPTO has given the A trademark a serial number of 97093752. The federal status of this trademark filing is REGISTERED as of Tuesday, April 8, 2025. This trademark is owned by ArriVent BioPharma, Inc.. The A trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer
a

General Information

Serial Number97093752
Word MarkA
Filing DateTuesday, October 26, 2021
Status700 - REGISTERED
Status DateTuesday, April 8, 2025
Registration Number7754969
Registration DateTuesday, April 8, 2025
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements

Description of MarkThe mark consists of a stylized letter "A".
Goods and Servicespharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer
Pseudo MarkARRI VENT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code005
First Use Anywhere DateThursday, November 14, 2024
First Use In Commerce DateThursday, November 14, 2024

Trademark Owner History

Party NameArriVent BioPharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewtown Square, PA 190733269
Party NameArriVent BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewtown Square, PA 190733269
Party NameArriVent BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewtown Square, PA 190733269

Trademark Events

Event DateEvent Description
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 29, 2021NEW APPLICATION ENTERED
Wednesday, August 3, 2022ASSIGNED TO EXAMINER
Wednesday, August 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 24, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, April 24, 2023DIVISIONAL REQUEST RECEIVED
Monday, April 24, 2023SOU EXTENSION 1 FILED
Wednesday, May 10, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 11, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, May 11, 2023SOU EXTENSION 1 GRANTED
Friday, May 12, 2023CORRECTED NOA E-MAILED
Friday, May 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 18, 2023SOU EXTENSION 2 FILED
Wednesday, October 18, 2023SOU EXTENSION 2 GRANTED
Friday, October 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 15, 2024SOU EXTENSION 3 FILED
Monday, April 15, 2024SOU EXTENSION 3 GRANTED
Thursday, October 31, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU EXTENSION 4 FILED
Thursday, October 31, 2024SOU EXTENSION 4 GRANTED
Monday, January 27, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 27, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 14, 2025USE AMENDMENT FILED
Friday, March 14, 2025TEAS STATEMENT OF USE RECEIVED
Monday, March 17, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 18, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 18, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 8, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, April 8, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

cancer pharmaceutical treatment products lung